Search Results

There are 33660 results for: content related to: Validation of a new scale for the evaluation of sialorrhea in patients with Parkinson's disease

  1. Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease

    Movement Disorders

    Volume 24, Issue 5, 15 April 2009, Pages: 635–646, Marian L. Evatt, K. Ray Chaudhuri, Kelvin L. Chou, Ester Cubo, Vanessa Hinson, Katie Kompoliti, Chengwu Yang, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins and Christopher G. Goetz

    Version of Record online : 9 FEB 2009, DOI: 10.1002/mds.22260

  2. Sialorrhea in Parkinson's disease: A review

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2306–2313, Kelvin L. Chou, Marian Evatt, Vanessa Hinson and Katie Kompoliti

    Version of Record online : 20 JUL 2007, DOI: 10.1002/mds.21646

  3. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis

    Intervention Review

    The Cochrane Library

    Carolyn A Young, Cathy Ellis, Julia Johnson, Sivakumar Sathasivam and Nicky Pih

    Published Online : 11 MAY 2011, DOI: 10.1002/14651858.CD006981.pub2

  4. Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease

    Movement Disorders

    Volume 26, Issue 2, 1 February 2011, Pages: 313–319, Arianna Guidubaldi, Alfonso Fasano, Tamara Ialongo, Carla Piano, Maurizio Pompili, Roberta Mascianà, Luisa Siciliani, Mario Sabatelli and Anna Rita Bentivoglio

    Version of Record online : 21 JAN 2011, DOI: 10.1002/mds.23473

  5. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis

    Muscle & Nerve

    Volume 34, Issue 2, August 2006, Pages: 235–237, Ashok Verma and Julie Steele

    Version of Record online : 31 MAR 2006, DOI: 10.1002/mus.20545

  6. Effect of recurrent onabotulinum toxin a injection into the salivary glands: An ultrasound measurement

    The Laryngoscope

    Volume 125, Issue 10, October 2015, Pages: E328–E332, Isabel Cardona, Christine Saint-Martin and Sam J. Daniel

    Version of Record online : 21 JUL 2015, DOI: 10.1002/lary.25222

  7. Volume matters: The influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis

    Muscle & Nerve

    Volume 47, Issue 2, February 2013, Pages: 276–278, Anagnostou Evangelos, Rentzos Michael, Alexakis Theodoros, Zouvelou Vasiliki, Zambelis Thomas and Evdokimidis Ioannis

    Version of Record online : 28 DEC 2012, DOI: 10.1002/mus.23692

    Corrected by:

    Erratum: Erratum

    Vol. 48, Issue 1, 155, Version of Record online: 12 JUN 2013

  8. The role of radiation therapy in the management of sialorrhea: A systematic review

    The Laryngoscope

    Volume 126, Issue 1, January 2016, Pages: 80–85, Nathan M. Hawkey, Nicholas G. Zaorsky and Thomas J. Galloway

    Version of Record online : 7 JUL 2015, DOI: 10.1002/lary.25444

  9. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations

    European Journal of Neurology

    Volume 13, Issue s1, February 2006, Pages: 60–64, E.-K. Tan

    Version of Record online : 15 SEP 2008, DOI: 10.1111/j.1468-1331.2006.01447.x

  10. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S42–S80, Klaus Seppi, Daniel Weintraub, Miguel Coelho, Santiago Perez-Lloret, Susan H. Fox, Regina Katzenschlager, Eva-Maria Hametner, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23884

  11. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial

    Movement Disorders

    Volume 27, Issue 2, February 2012, Pages: 219–226, Robert Chinnapongse, Kristen Gullo, Paul Nemeth, Yuxin Zhang and Lynn Griggs

    Version of Record online : 1 SEP 2011, DOI: 10.1002/mds.23929

  12. Treatment of sialorrhea in amyotrophic lateral sclerosis

    Acta Neurologica Scandinavica

    Volume 117, Issue s188, May 2008, Pages: 77–81, O.-B. Tysnes

    Version of Record online : 24 APR 2008, DOI: 10.1111/j.1600-0404.2008.01037.x

  13. Clinical Study of Botulinum-A Toxin in the Treatment of Sialorrhea in Children With Cerebral Palsy

    The Laryngoscope

    Volume 112, Issue 1, January 2002, Pages: 73–81, Dana L. Suskind and Ann Tilton

    Version of Record online : 2 JAN 2009, DOI: 10.1097/00005537-200201000-00014

  14. Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead

    Muscle & Nerve

    Volume 45, Issue 3, March 2012, Pages: 311–318, Leslie J. Blackhall

    Version of Record online : 13 FEB 2012, DOI: 10.1002/mus.22305

  15. Other Non-Motor Symptoms of Parkinson's Disease

    Parkinson's Disease: Non-Motor and Non-Dopaminergic Features

    Mark J. Edwards, Kailash P. Bhatia, Pages: 387–393, 2011

    Published Online : 27 JUN 2011, DOI: 10.1002/9781444397970.ch34

  16. Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment

    Human Psychopharmacology: Clinical and Experimental

    Volume 29, Issue 4, July 2014, Pages: 336–341, Anssi Solismaa, Olli Kampman, Niko Seppälä, Merja Viikki, Kari-Matti Mäkelä, Nina Mononen, Terho Lehtimäki and Esa Leinonen

    Version of Record online : 19 MAY 2014, DOI: 10.1002/hup.2408

  17. Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism

    Movement Disorders

    Volume 22, Issue 16, 15 December 2007, Pages: 2430–2435, Anna-Gerlind Postma, Mart Heesters and Teus van Laar

    Version of Record online : 25 OCT 2007, DOI: 10.1002/mds.21752

  18. Oro-buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort

    European Journal of Neurology

    Volume 19, Issue 1, January 2012, Pages: 28–37, S. Perez-Lloret, L. Nègre-Pagès, A. Ojero-Senard, P. Damier, A. Destée, F. Tison, M. Merello, O. Rascol and for the COPARK Study Group

    Version of Record online : 1 APR 2011, DOI: 10.1111/j.1468-1331.2011.03402.x

  19. Therapeutic Options in the Treatment of Clozapine-Induced Sialorrhea

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 20, Issue 9, September 2000, Pages: 1092–1095, Donald P. Rogers and Jennifer K. Shramko

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.20.13.1092.35036

  20. You have free access to this content
    Botulinum toxin for drooling in Parkinson’s disease

    Intervention Protocol

    The Cochrane Library

    Fiona Hill, Nick Miller, Richard A Walsh, David Mockler, Ronald McDowell and Margaret Walshe

    Published Online : 28 OCT 2016, DOI: 10.1002/14651858.CD012408